ArticleJCO precision oncology2018

Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung Cancer.

Zofia Piotrowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.